Fenretinide Activates a Distinct Apoptotic Pathway
- 31 August 2004
- journal article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 96 (17) , 1264-1265
- https://doi.org/10.1093/jnci/djh268
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Gangliosides Link the Acidic Sphingomyelinase-Mediated Induction of Ceramide to 12-Lipoxygenase-Dependent Apoptosis of Neuroblastoma in Response to FenretinideJNCI Journal of the National Cancer Institute, 2004
- Retinoids in cancer therapy and chemoprevention: promise meets resistanceOncogene, 2003
- Synergistic Cytotoxicity in Solid Tumor Cell Lines Between N-(4-Hydroxyphenyl)retinamide and Modulators of Ceramide MetabolismJNCI Journal of the National Cancer Institute, 2000
- Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast CancerJNCI Journal of the National Cancer Institute, 1999
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARγ independent pathwayOncogene, 1999
- Involvement of Reactive Oxygen Species in N-(4-Hydroxyphenyl)retinamide-Induced Apoptosis in Cervical Carcinoma CellsJNCI Journal of the National Cancer Institute, 1997
- Role of antioxidants and intracellular free radicals in retinamide- induced cell deathCarcinogenesis: Integrative Cancer Research, 1997
- 4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid ReceptorsJournal of Biological Chemistry, 1996
- Retinoids and Apoptosis: Implications for Cancer Chemoprevention and TherapyJNCI Journal of the National Cancer Institute, 1995